secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2024-07-12T23:59:59+00:00
Accession:  0001193125-24-178607
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics receives Nasdaq bid-price deficiency notice; 180 days to cure
--------------------------------------------------------------------------------

- Nasdaq notified Sensei on July 10, 2024 that common stock closed below $1.00 for 30 consecutive business days.
- Company has until January 6, 2025 to regain compliance by closing at $1.00 or more for at least 10 consecutive days.
- If not cured, may transfer to Nasdaq Capital Market with $5,000 fee and meet other listing standards.
- Options to cure include potential reverse stock split; no assurance of maintaining listing.
- Notice has no immediate impact on trading; Company will monitor and consider available remedies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524178607/0001193125-24-178607-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524178607/d853366d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-178607

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer